DK580886D0 - Dna-sekvens - Google Patents

Dna-sekvens

Info

Publication number
DK580886D0
DK580886D0 DK580886A DK580886A DK580886D0 DK 580886 D0 DK580886 D0 DK 580886D0 DK 580886 A DK580886 A DK 580886A DK 580886 A DK580886 A DK 580886A DK 580886 D0 DK580886 D0 DK 580886D0
Authority
DK
Denmark
Prior art keywords
dna
dna sequence
dna fragment
desired polypeptide
coding
Prior art date
Application number
DK580886A
Other languages
English (en)
Other versions
DK580886A (da
Inventor
Henrik Dalbaege Andersen
Hans Henrik Marstrand Dahl
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK580886A priority Critical patent/DK580886A/da
Publication of DK580886D0 publication Critical patent/DK580886D0/da
Publication of DK580886A publication Critical patent/DK580886A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
DK580886A 1985-04-03 1986-12-03 Dna-sekvens DK580886A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK580886A DK580886A (da) 1985-04-03 1986-12-03 Dna-sekvens

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK151585A DK151585D0 (da) 1985-04-03 1985-04-03 Dna-sekvens
PCT/DK1986/000029 WO1986005804A1 (en) 1985-04-03 1986-04-03 A dna sequence
DK580886A DK580886A (da) 1985-04-03 1986-12-03 Dna-sekvens

Publications (2)

Publication Number Publication Date
DK580886D0 true DK580886D0 (da) 1986-12-03
DK580886A DK580886A (da) 1986-12-03

Family

ID=8105641

Family Applications (2)

Application Number Title Priority Date Filing Date
DK151585A DK151585D0 (da) 1985-04-03 1985-04-03 Dna-sekvens
DK580886A DK580886A (da) 1985-04-03 1986-12-03 Dna-sekvens

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK151585A DK151585D0 (da) 1985-04-03 1985-04-03 Dna-sekvens

Country Status (7)

Country Link
EP (1) EP0218651B1 (da)
JP (1) JP2612264B2 (da)
AT (1) ATE92961T1 (da)
AU (1) AU5695086A (da)
DE (1) DE3688870T2 (da)
DK (2) DK151585D0 (da)
WO (1) WO1986005804A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340725A (en) * 1986-10-09 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Expression vector for insulin-like growth factor I and method of production
DE3783305T2 (de) * 1986-10-09 1993-05-19 Fujisawa Pharmaceutical Co Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
JPH04503154A (ja) * 1988-11-07 1992-06-11 ルニベルシー・ド・ルタ・ア・リージュ 変型ヒト成長ホルモン
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
EP1881005B1 (en) * 1997-07-14 2013-04-03 Bolder Biotechnology, Inc. Derivatives of G-CSF and related proteins
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7446183B2 (en) 2000-06-16 2008-11-04 Asterion Limited Fusion protein comprising growth hormone and growth hormone receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2963374D1 (en) * 1978-10-10 1982-09-09 Univ Leland Stanford Junior Recombinant dna, method for preparing it and production of foreign proteins by unicellular hosts containing it
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS5967297A (ja) * 1982-10-08 1984-04-16 Kyowa Hakko Kogyo Co Ltd 新規ベクタ−
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
JPS60502136A (ja) * 1983-08-10 1985-12-12 アムジエン　インコーポレイテツド 微生物によるインタ−ル−キン２の形質発現

Also Published As

Publication number Publication date
EP0218651A1 (en) 1987-04-22
JPS62502657A (ja) 1987-10-15
DK151585D0 (da) 1985-04-03
DE3688870T2 (de) 1993-12-23
WO1986005804A1 (en) 1986-10-09
AU5695086A (en) 1986-10-23
DE3688870D1 (de) 1993-09-16
EP0218651B1 (en) 1993-08-11
DK580886A (da) 1986-12-03
ATE92961T1 (de) 1993-08-15
JP2612264B2 (ja) 1997-05-21

Similar Documents

Publication Publication Date Title
DE3382760D1 (de) Herstellung von funktionellen menschlichen Urokinasepolypeptiden.
DK120387D0 (da) Hybridinterferoner, deres anvendelse som laegemiddel og mellemprodukter til fremstilling af antistoffer og disses anvendelse samt fremgangsmaade til deres fremstilling
DK576782A (da) Bicycliske aminosyrer, fremgangsmaader og mellemprodukter til deres fremstilling og deres anvendelse
DK221589A (da) Fremgangsmaade til at udtrykke ikke-gaerprotein i en gaervaert og transformeret gaervaert
DK130683A (da) Derivater af bicycliske aminosyrer, fremgangsmaader til fremstilling deraf, midler indeholdende disse forbindelser og deres anvendelse samt bicycliske aminosyrer som mellemprodukter og fremgangsmaade til fremstilling heraf
NO834128L (no) Nye derivater av tricykliske aminosyrer, fremgangsmaate til deres fremstilling, midler som inneholder disse, og deres anvendelse, samt nye bicykliske aminosyrer som mellomprodukter og fremgangsmaate til deres fremstilling
DK430486D0 (da) Fremgangsmaade til udvinding af protein
DK580886A (da) Dna-sekvens
ES547436A0 (es) Un procedimiento para producir un adn complementario clonadoo su adn modificado que codifica un polipeptido de factor denecrosis de tumores
NO174161C (no) Fremgangsmåte for fremstilling av humane interferon--polypeptidderivater, og rekombinante plasmider inneholdende et DNA-fragment som koder for polypeptidene
DE3481386D1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
NO861772L (no) Fremgangsmaate for fremstilling av proteinhydrolysat.
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
ES547600A0 (es) Procedimiento para preparar proteinas encarioticas, procarioticas o viricas.
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
DK592986D0 (da) Fremgangsmaade til ydelsesfremme hos nyttedyr, aminophenylethylaminderivater, samt fremgangsmaade til fremstilling deraf
DE3683178D1 (de) Methode zur herstellung monoklonaler antikoerper gegen plasminogenaktivatorfaktor.
DK130290A (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DK661489A (da) Ekspressionsplasmider til ekspression af proteiner i e. coli og deres anvendelse
DK107785A (da) Ekspressionsplasmider, der kan anvendes i b.subtilis til fremstillingaf prochymosin, og fremgangsmaade til fremstilling af plasmider
NO178704C (no) DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
DK268687D0 (da) Fremgangsmaade til fremstilling af cykloalkancarbonsyrer

Legal Events

Date Code Title Description
ATS Application withdrawn